Pubblicazioni

Phosphorylation, mgâadp, and inhibitors differentially shape the conformational dynamics of the aâloop of auroraâa

2021 - BIOMOLECULES

Musavizadeh, Z.; Grottesi, A.; Guarguaglini, G.; Paiardini, A.

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

2021 - ANNALS OF HEMATOLOGY

Scalzulli, E.; Caocci, G.; Efficace, F.; Rizzo, L.; Colafigli, G.; Di Prima, A.; Pepe, S.; Fegatelli, D. A.; Carmosino, I.; Diverio, D.; Latagliata, R.; La Nasa, G.; Martelli, M.; Foa, R.; Breccia, M.

Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events

2018 - ANNALS OF HEMATOLOGY

Molica, Matteo; Scalzulli, Emilia; Colafigli, Gioia; Alunni Fegatelli, Danilo; Massaro, Fulvio; Latagliata, Roberto; FoÃ , Robin; Breccia, Massimo

Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life

2017 - AMERICAN JOURNAL OF HEMATOLOGY

Breccia, Massimo; Colafigli, Gioia; Molica, Matteo; Scalzulli, Emilia; Diverio, Daniela; Latagliata, Roberto; Guarini, Anna; FoÃ , Robin

Pubblicazioni

Phosphorylation, mgâadp, and inhibitors differentially shape the conformational dynamics of the aâloop of auroraâa

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events

Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life

Phosphorylation, mgâadp, and inhibitors differentially shape the conformational dynamics of the aâloop of auroraâa